(Y54) Agents primarily affecting water-balance and mineral and uric acid metabolism

More details coming soon

Icon
23 983 in individuals diagnosis agents primarily affecting water-balance and mineral and uric acid metabolism confirmed
Icon
1 816 deaths with diagnosis agents primarily affecting water-balance and mineral and uric acid metabolism
Icon
8% mortality rate associated with the disease agents primarily affecting water-balance and mineral and uric acid metabolism

Diagnosis agents primarily affecting water-balance and mineral and uric acid metabolism is diagnosed Women are 44.36% more likely than Men

6 672

Men receive the diagnosis agents primarily affecting water-balance and mineral and uric acid metabolism

1 476 (22.1 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
17 311

Women receive the diagnosis agents primarily affecting water-balance and mineral and uric acid metabolism

340 (2.0 %)

Died from this diagnosis.

Risk Group for the Disease agents primarily affecting water-balance and mineral and uric acid metabolism - Men aged 25-29 and Women aged 65-69

Icon
In Men diagnosis is most often set at age 0-5, 25-29, 45-49, 55-59, 70-84
Icon
Less common in men the disease occurs at Age 0-1, 5-24, 30-44, 50-54, 60-69, 85-95+Less common in women the disease occurs at Age 0-59, 85-94
Icon
In Women diagnosis is most often set at age 60-84, 95+

Disease Features agents primarily affecting water-balance and mineral and uric acid metabolism

Icon
Absence or low individual and public risk
Icon

Agents primarily affecting water-balance and mineral and uric acid metabolism - what does this mean

Agents primarily affecting water-balance and mineral and uric acid metabolism are diseases that are caused by abnormal levels of electrolytes, minerals, and uric acid in the blood. these can be caused by dehydration, kidney or liver disorders, or certain medications. symptoms may include thirst, fatigue, confusion, and muscle cramps. treatment may involve adjusting diet, taking medications, and providing fluids.

What happens during the disease - agents primarily affecting water-balance and mineral and uric acid metabolism

This disease is caused by an imbalance in the body's water-balance and mineral and uric acid metabolism. this imbalance can be caused by a variety of agents, including medications, dehydration, dietary changes, and underlying medical conditions. this can lead to a variety of symptoms, such as fatigue, headaches, muscle cramps, and changes in blood pressure. treatment typically involves correcting the underlying cause, as well as adjusting the patient's diet and lifestyle to restore balance.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Complete Blood Count (CBC)
  • Urinalysis
  • Renal Function Tests
  • Electrolyte Panel
  • Uric Acid Test
  • Thyroid Function Tests
  • Hormone Tests
  • Imaging Tests
  • Liver Function Tests
  • 24-Hour Urine Collection

Treatment and Medical Assistance

Main Goal: To regulate water-balance, mineral and uric acid metabolism
  • Monitor fluid intake and output
  • Administer medications to restore electrolyte balance
  • Provide dietary and lifestyle advice to reduce uric acid levels
  • Prescribe diuretics to reduce water retention
  • Prescribe medications to reduce uric acid levels
  • Monitor uric acid levels regularly
  • Prescribe supplements to restore mineral balance
  • Provide education about dietary and lifestyle changes to maintain electrolyte balance
Icon
15 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Agents primarily affecting water-balance and mineral and uric acid metabolism - Prevention

The prevention of agents primarily affecting water-balance and mineral and uric acid metabolism can be achieved by maintaining a healthy lifestyle, including regular exercise, a balanced diet, adequate hydration, and avoiding excessive alcohol consumption. additionally, regular check-ups with a healthcare provider and screening for these agents can help to identify and address any potential issues before they become more serious.

Specified forms of the disease

(Y54.0) Mineralocorticoids
(Y54.1) Mineralocorticoid antagonists [aldosterone antagonists]
(Y54.2) Carbonic-anhydrase inhibitors
(Y54.3) Benzothiadiazine derivatives
(Y54.4) Loop [high-ceiling] diuretics
(Y54.5) Other diuretics
(Y54.6) Electrolytic, caloric and water-balance agents
(Y54.7) Agents affecting calcification
(Y54.8) Agents affecting uric acid metabolism
(Y54.9) Mineral salts, not elsewhere classified